Jump to navigation
DENVER – Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accura
DENVER – Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC).
DENVER – The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 i
DENVER – ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (
DENVER – Most lung cancers are detected when patients become symptomatic and have latestage disease.
DENVER – Sarcomatoid carcinomas of the lung include rare subtypes of poorly differentiated non–small-cell lung carcinomas of high grade and aggress
Join the only international association solely dedicated to lung cancer research and treatment.
The IASLC’s premier journal, emphasizing a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews and opinion pieces. Visit JTO
IASLC 40th Anniversary Page